Drug Name |
CLX-0921
|
Synonyms |
CLX-090502; CLX-090503; CLX-090717; CLX-092402 |
Indication |
Disease Entry |
ICD 11 |
Status |
REF |
Type-2 diabetes |
5A11
|
Phase 1 |
[1] |
------------------------------------------------------------------------------------ |
|
|
|
|
Structure |
|
|
3D MOL
|
2D MOL
|
#Ro5 Violations (Lipinski): 2 |
Molecular Weight (mw) |
519.6 |
|
Logarithm of the Partition Coefficient (xlogp) |
5.4 |
Rotatable Bond Count (rotbonds) |
10 |
Hydrogen Bond Donor Count (hbonddonor) |
1 |
Hydrogen Bond Acceptor Count (hbondacc) |
8 |
Chemical Identifiers |
- Formula
- C28H25NO7S
- IUPAC Name
methyl (E)-3-(3,5-dimethoxyphenyl)-2-[4-[4-[(2,4-dioxo-1,3-thiazolidin-5-yl)methyl]phenoxy]phenyl]prop-2-enoate
- Canonical SMILES
-
COC1=CC(=CC(=C1)/C=C(\\C2=CC=C(C=C2)OC3=CC=C(C=C3)CC4C(=O)NC(=O)S4)/C(=O)OC)OC
- InChI
-
InChI=1S/C28H25NO7S/c1-33-22-12-18(13-23(16-22)34-2)14-24(27(31)35-3)19-6-10-21(11-7-19)36-20-8-4-17(5-9-20)15-25-26(30)29-28(32)37-25/h4-14,16,25H,15H2,1-3H3,(H,29,30,32)/b24-14+
- InChIKey
-
IVAQJHSXBVHUQT-ZVHZXABRSA-N
|
Cross-matching ID |
- PubChem CID
- 9958278
- CAS Number
-
- DrugBank ID
-
- TTD ID
- D06TWE
|
|
|
|
|
|
|
|